Vandana Singh
·
August 11, 2025
Benzinga
Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.
read more
October 4, 2025
September 5, 2025
August 2, 2025
August 3, 2025
Barchart
August 26, 2025
Fortune